Enzo Biochem, Inc. (ENZ) Reports Q2 Loss of $0.04

Enzo Biochem, Inc. (NYSE: ENZ) reported Q2 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $25 million, versus $23.7 million reported last year.

For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits